Patient-reported health preferences of anticoagulant-related outcomes

Ye Wang, Feng Xie, Ming Chai Kong, Lai Heng Lee, Heng Joo Ng, Yu Ko

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)


Strokes can have a catastrophic impact on patients’ health-related quality of life (HRQoL). In addition to warfarin, two novel oral anticoagulants, i.e., dabigatran and rivaroxaban, have been approved to prevent strokes. This study aimed to use direct measures to elicit patient-reported utilities (i.e., preferences) for anticoagulant-related outcomes. A cross-sectional survey was administered to 100 patients taking warfarin in an anticoagulation clinic. Utilities for six long-term and four short-term anticoagulant-related health states were elicited by the visual analogue scale (VAS) and standard gamble (SG) methods. Health states with the highest SG-derived mean utility values were “well on rivaroxaban” (mean ± SD = 0.90 ± 0.15), “well on warfarin” (0.86 ± 0.17), and “well on dabigatran” (0.83 ± 0.18). Approximately half of the patients considered major ischemic stroke (−1.57 ± 6.77) and intracranial hemorrhage (−1.99 ± 6.98) to be worse than death. The percentages of patients who considered a particular health state worse than death ranged from 0 to 55 % among various health states assessed. The VAS had similar findings. Good logical consistency was observed in both VAS- and SG-derived utility values. Ischemic stroke and intracranial hemorrhage had a significant impact on patients’ HRQoL. Greater variation in patients’ preferences was observed for more severely impaired health states, indicating the need for individualized medical decision-making. In this study, both long-term and short-term health states were included in the utility assessment. The findings of this study can be used in cost-utility analysis of future anticoagulation therapies.

Original languageEnglish
Pages (from-to)268-273
Number of pages6
JournalJournal of Thrombosis and Thrombolysis
Issue number3
Publication statusPublished - Oct 24 2015


  • Anticoagulant
  • Preference
  • Stroke
  • Utility
  • Warfarin

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Patient-reported health preferences of anticoagulant-related outcomes'. Together they form a unique fingerprint.

Cite this